NEORX CORP
S-3/A, EX-23.1, 2000-10-06
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: NEORX CORP, S-3/A, 2000-10-06
Next: REICH & TANG EQUITY FUND INC, 40-8F-M, 2000-10-06



<PAGE>   1


                                  Exhibit 23.1

               CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS


The Board of Directors
NeoRx Corporation:

        We consent to the use of our report incorporated herein by reference and
to the reference to our firm under the heading "Experts" in the prospectus.



                                            /s/ KPMG LLP
                                            ------------------------------------
                                            KPMG LLP


Seattle, Washington

October 6, 2000



                                      II-5



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission